In Vivo Biodistribution and Efficacy Evaluation of NeoB, A Radiotracer Targeted to GRPR, in Mice Bearing Gastrointestinal Stromal Tumor

SIMPLE SUMMARY: NeoB is undergoing evaluation as a novel theragnostic agent—that is, that it can be employed either for the diagnosis of tumor expressing gastrin-releasing peptide receptor (GRPR) using nuclear imaging, or for the therapy of such GRPR positive tumors using internal radiotherapy. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Montemagno, Christopher, Raes, Florian, Ahmadi, Mitra, Bacot, Sandrine, Debiossat, Marlène, Leenhardt, Julien, Boutonnat, Jean, Orlandi, Francesca, Barbato, Donato, Tedesco, Mattia, Ghezzi, Catherine, Perret, Pascale, Broisat, Alexis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958597/
https://www.ncbi.nlm.nih.gov/pubmed/33801382
http://dx.doi.org/10.3390/cancers13051051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958597/
https://www.ncbi.nlm.nih.gov/pubmed/33801382
http://dx.doi.org/10.3390/cancers13051051

Ejemplares similares